Cancer of the cervix
Cancer of the cervix is the second most common cancer in women worldwide, with about 500 000 new cases and 250 000 deaths each year. Almost 80% of cases occur in low-income countries, where cervical cancer is the second most common cancer in women. Virtually all cervical cancer cases (99%) are linked to genital infection with human papillomavirus (HPV), which is the most common viral infection of the reproductive tract.
Clinical management
Comprehensive cervical cancer control - a guide to essential practice
This guide focuses on the knowledge and skills needed by health care providers, at different levels of care, in order to offer quality services for prevention, screening, treatment of cervical cancer.
Human papillomavirus vaccines (HPV)
In response to new etiologic evidence, improved technology, and promising HPV vaccine efforts, cervical cancer epidemiologic and preventive efforts are being reshaped throughout the world. Activities are focused on preparing for HPV vaccine introduction in developing countries.
Prevention and control
- Cancer of the cervix
- Clinical management
- Human papillomavirus vaccines (HPV)
